CD8A and neoplasm: Various tumor specificities of CD8+ T lymphocytes in TDLN and in the tumor microenvironment can be monitored with H-2kb tetramers refolded with well-studied immunodominant CTL epitopes such as Ovalbumin (OVA) and TRP2 in B16-OVA, and gp70 in the MC38 model.